Parallax Volatility Advisers
CODX

Parallax Volatility Advisers’s Co-Diagnostics CODX Stock Holding History

Parallax Volatility Advisers’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7
Closed -$522 – 2780
2022
Q4 		$522 Hold
7
– – ﹤0.01% 2767
2022
Q3 		$1K Buy
+7
New +$979 ﹤0.01% 2990

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Parallax Volatility Advisers's CODX Position: Q1 2023 in Review

Parallax Volatility Advisers sold out of Co-Diagnostics (CODX) in Q1 2023, closing a stake of 7 shares — an estimated $522 sold.

Parallax Volatility Advisers first reported a position in CODX in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q3 2022. 51 funds tracked by Wall St. Rank hold CODX as of Q1 2023.

  • Parallax Volatility Advisers reported no remaining Co-Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 7 Co-Diagnostics shares in Q1 2023, an estimated $522.
  • Parallax Volatility Advisers first reported a position in Co-Diagnostics in Q3 2022 and held it in 2 quarters.
  • Parallax Volatility Advisers's Co-Diagnostics position peaked at $1K in Q3 2022.
  • 51 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2023.

Based on Parallax Volatility Advisers's 13F filing for Q1 2023, filed 15 May 2023.